Guangtong Deng is currently a researcher and dermatologist at Xiangya Hospital of Central South University. From 2010 to 2019, he completed his undergraduate, master's, and doctoral studies in the 8-year clinical medicine program at Central South University. Between 2016 and 2018, he conducted visiting research at the Houston Methodist Research Institute in the United States. From 2019 to 2022, he served as an Assistant Researcher at Xiangya Hospital, Central South University, followed by a role as a Specially Appointed Associate Researcher from 2022 to 2023. Since 2023, he has held the position of full Researcher at Xiangya Hospital. Guangtong Deng has long been dedicated to mechanistic and translational research on targeting cell death for melanoma treatment. Over the past five years, his key achievements include: ① Systematic elucidation of critical targets and mechanisms driving melanoma resistance to cell death and subsequent malignant progression. ② Development of monotherapy and combination therapy strategies targeting cell death pathways for melanoma treatment. ③ Construction of cell death-based predictive models for drug efficacy assessment and disease prognosis evaluation. Based on these accomplishments, Guangtong Deng has been invited to serve as Associate Editor of Frontiers in Medicine, Youth Editorial Board Member of Journal of Translational Internal Medicine, and Guest Editor for Biomedicines.
Senior Scientist or Principal Investigator
Xiangya Hospital Central South University, Changsha, China
01 Aug 2023 - 01 Apr 2025